tiprankstipranks

Christopher Henney Insider Profile

4 Followers
Christopher Henney, Director at Anthera Pharmaceuticals, holds 39.41K shares in Cyclacel Pharmaceuticals (Ticker: CYCC), holds 0.00 shares in Prothena (Ticker: PRTA), holds 0.00 shares in Cascadian Therapeutics (Ticker: CASC).
tipranks
Christopher Henney

Christopher Henney
Anthera Pharmaceuticals (ANTH)
Director

Ranked #82,853 out of 97,372 Corporate Insiders

Profitable Transactions

14%
2 out of 14 Profitable Transactions

Average Return

-14.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$119K
92.40%
7.60%
0.00%
0.00%
A breakdown of Christopher Henney's holdings

Insider Roles

Cyclacel Pharmaceuticals
(CYCC)
Director
Anthera Pharmaceuticals
(ANTH)
Director
Prothena
(PRTA)
Director
Sarepta Therapeutics
(SRPT)
Director
Roles that Christopher Henney holds in companies

Most Profitable Insider Trade

Stock:
Cascadian Therapeutics
(CASC)
Rating:Informative Buy
Date:Feb 01, 2017 - Feb 01, 2018
Return:+136.50%
The most profitable trade made by Christopher Henney

Christopher Henney's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Anthera Pharmaceuticals
Jul 02, 2012
Director
Informative Buy
148.00K
$9.07K
CASC
Cascadian Therapeutics
Mar 13, 2018
Uninformative Sell
$0.00
Cyclacel Pharmaceuticals
Jul 03, 2023
Director
Uninformative Buy
$110.36K
Prothena
Jul 16, 2021
Director
Informative Buy
125.85K
$0.00
Sarepta Therapeutics
Director
$0.00
List of latest transactions for each holding click on a transaction to see Christopher Henney's performance on stock

Christopher Henney insider profile FAQ

What is the percentage of profitable transactions made by Christopher Henney?
The percentage of profitable transactions made by Christopher Henney is 14%.
    What is the average return per transaction made by Christopher Henney?
    The average return per transaction made by Christopher Henney is -14.90%.
      What stocks does Christopher Henney hold?
      Christopher Henney holds: ANTH, CASC, CYCC, PRTA, SRPT stocks.
        What was Christopher Henney’s latest transaction?
        Christopher Henney latest transaction was an Uninformative Buy of ―.
          What was Christopher Henney's most profitable transaction?
          Christopher Henney’s most profitable transaction was an Informative Buy of CASC stock on February 1, 2017. The return on the trade was 136.50%.
            What is Christopher Henney's role in Anthera Pharmaceuticals?
            Christopher Henney's role in Anthera Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.